SCHEMBL3740329

SCHEMBL3740329

CC(C)(C)OC(=O)N(C=O)C(CO)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.43
BACE1 P56817 1/20 0.41
ITGA4 P13612 1/20 0.40
ITGB7 P26010 1/20 0.40
OPRM1 P35372 2/20 0.40
OPRD1 P41143 2/20 0.40
OPRK1 P41145 2/20 0.40
CTSS P25774 2/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSK P43235 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 1/20 0.38
ACE P12821 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
AKT1 P31749 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316889 0.82 ATM (0.43) ATMBACE1ITGA4ITGB7OPRM1
SCHEMBL27489128 0.82 ATM (0.43) ATMBACE1ITGA4ITGB7OPRM1
SCHEMBL2473923 0.82 ATM (0.43) ATMBACE1ITGA4ITGB7OPRM1
SCHEMBL3740158 0.82 ATM (0.38) ATMBACE1ITGA4ITGB7OPRM1
SCHEMBL27459831 0.81 BACE1 (0.48) ATMBACE1ITGA4ITGB7CTSS
SCHEMBL4973190 0.81 BACE1 (0.48) ATMBACE1ITGA4ITGB7CTSS
SCHEMBL14292697 0.80 BACE1 (0.42) ATMBACE1ITGA4ITGB7OPRM1
SCHEMBL3736566 0.80 CYP1A2 (0.43) OPRM1OPRD1OPRK1CYP1A2SLC7A5
SCHEMBL13826644 0.80 CTSS (0.42) ATMITGA4ITGB7OPRM1OPRD1
SCHEMBL4729192 0.80 OPRK1 (0.40) ATMBACE1OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829304-B2 Compounds and related methods for mutant p53 reactivation NORTHWESTERN UNIVERSITY (US) 2010-11-09 US disclosed
US-20080206805-A1 Compounds and Related Methods for Mutant p53 Reactivation APPELLA DANIEL H 2008-08-28 US disclosed
US-7329775-B2 Compounds and related methods for mutant p53 reactivation NORTHWESTERN UNIVERSITY (US) 2008-02-12 US disclosed
US-20050245616-A1 Compounds and related methods for mutant p53 reactivation NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-11-03 US disclosed
WO-2005042481-A2 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION NORTHWESTERN UNIVERSITY (US) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245616-A1 Compounds and related methods for mutant p53 reactivation TP53, TP53BP1, MDM2 ATM 340/4885BACE1 3325/4885ITGA4 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.